Experimental Investigation of Lung Toxicity after Radiation Therapy Combined with Immune Checkpoint Inhibitors

被引:0
|
作者
Rotgerink, L. Lansink [1 ]
Burkhardt, R. [1 ,2 ]
Groll, T. [3 ,4 ]
Felchle, H. [1 ]
Nefzger, S. M. [5 ]
Walther, C. N. [5 ]
Gissibl, J. [1 ]
Timnik, V. R. [1 ]
Dobiasch, S. [1 ]
Steiger, K. [6 ,7 ]
Combs, S. E. [1 ,8 ]
Wilkens, J. [1 ,2 ]
Fischer, J. [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Sch Med, Dept Radiat Oncol, Munich, Germany
[2] Tech Univ Munich, Dept Phys, Munich, Germany
[3] Tech Univ Munich, Sch Med, Comparat Expt Pathol, Munich, Germany
[4] Tech Univ Munich, Inst Pathol, Sch Med, Munich, Germany
[5] Tech Univ Munich TUM, Klinikum Rechts Isar, Dept Radiat Oncol, Munich, Germany
[6] Tech Univ Munich, Comparat Expt Pathol, Munich, Germany
[7] Tech Univ Munich, Inst Pathol, Munich, Germany
[8] Helmholtz Zentrum Munchen, Inst Radiat Med IRM, Neuherberg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2525
引用
收藏
页码:E243 / E244
页数:2
相关论文
共 50 条
  • [31] Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases
    Moskalenko, Marina
    Robin, Tyler P.
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (05) : 2527 - 2536
  • [32] Toxicity of Sequential Tyrosine Kinase Inhibitors After Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer
    Jones, L.
    Rittberg, R.
    Leung, B.
    Shokoohi, A.
    Pender, A.
    Wong, S.
    Al-Hashami, Z.
    Wang, Y.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S444 - S444
  • [33] Immune checkpoint inhibitors in lung cancer
    Koleczko, S.
    Wolf, J.
    INTERNIST, 2020, 61 (07): : 676 - 681
  • [34] Advances in immune checkpoint inhibitors therapy for small cell lung cancer
    Li, Longhui
    Liang, Yangyueying
    Yu, Minghui
    Zhao, Lu
    Mei, Qingyun
    Yu, Yongchao
    Wang, Na
    Zhang, Dou
    Wang, Ziwei
    Jia, Yingjie
    Kong, Fanming
    CANCER MEDICINE, 2023, 12 (10): : 11097 - 11106
  • [35] Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon
    Beth A. Helmink
    Christina L. Roland
    Colleen M. Kiernan
    Jennifer A. Wargo
    Annals of Surgical Oncology, 2020, 27 : 1533 - 1545
  • [36] Toxicity of Immune Checkpoint Inhibitors: Considerations for the Surgeon
    Helmink, Beth A.
    Roland, Christina L.
    Kiernan, Colleen M.
    Wargo, Jennifer A.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1533 - 1545
  • [37] A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy
    Kottschade, Lisa
    Brys, Adam
    Peikert, Tobias
    Ryder, Mabel
    Raffals, Laura
    Brewer, Jerry
    Mosca, Paul
    Markovic, Svetomir
    MELANOMA RESEARCH, 2016, 26 (05) : 469 - 480
  • [38] Immune mechanisms of toxicity from checkpoint inhibitors
    Wang, S. Jennifer
    Dougan, Stephanie K.
    Dougan, Michael
    TRENDS IN CANCER, 2023, 9 (07) : 543 - 553
  • [39] Incidence of Pneumonitis in Metastatic Lung Cancer Patients Receiving Immune Checkpoint Inhibitors With or Without Thoracic Radiation Therapy
    Hwang, W.
    Niemierko, A.
    Willers, H.
    Gainor, J.
    Keane, F. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S150 - S150
  • [40] Pneumonitis in a patient treated with chemotherapy, radiation, and immune checkpoint inhibitors for SCC of the lung
    Van Dreumel, C.
    Marler, A. C.
    Loghmani, A.
    Dubuc, J.
    Moise, H. Oddo
    Engel, L. S.
    Walvekar, S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S139 - S139